CAFARO DEBRA A 4
4 · Ventas, Inc. · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
Ventas (VTR) CEO Debra Cafaro Exercises Options, Sells Shares
What Happened
- Debra A. Cafaro, Chairman and CEO of Ventas, exercised 10,322 fully vested stock options and immediately sold the 10,322 underlying shares on February 6, 2026. The exercise was reported as an acquisition at $73.71 per share (total $760,835) and the subsequent sale was at a weighted-average price of $82.23 per share (total proceeds $848,751). The transactions were effected under a pre-existing Rule 10b5-1 trading plan.
Key Details
- Transaction date: 2026-02-06.
- Option exercise: 10,322 shares acquired at $73.71 each (total $760,835).
- Sale: 10,322 shares sold at a weighted-average $82.23 each (total $848,751); reported sale prices ranged $82.00–$82.76.
- Derivative disposition: 10,322 option units were converted/exercised (reported as disposed at $0.00 in the derivative line).
- Notable footnotes: Options were fully vested and scheduled to expire within six months; the sale was conducted net of exercise price and taxes pursuant to a 10b5-1 plan (entered March 28, 2024). The reporter will provide per-price breakdown on request.
- Shares owned after the transaction: not stated in the supplied filing.
- Filing timeliness: Report filed Feb 10, 2026 for a Feb 6 transaction (filed within the normal Form 4 reporting window).
Context
- This was an exercise followed by an immediate sale (a common "cashless" or net exercise pattern), not a straight open-market purchase. Such transactions are often routine executions of option-holder liquidity or tax-withholding arrangements and—because they were done under a 10b5-1 plan—were pre-scheduled rather than ad hoc trades. The filing is informational and does not, by itself, indicate the insider’s view of the company.
Insider Transaction Report
Form 4
Ventas, Inc.VTR
CAFARO DEBRA A
DirectorChairman and CEO
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-06$73.71/sh+10,322$760,835→ 1,124,356 total - Sale
Common Stock
[F1][F2]2026-02-06$82.23/sh−10,322$848,751→ 1,114,034 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F3]2026-02-06−10,322→ 0 totalExercise: $73.71From: 2016-08-03Exp: 2026-08-03→ Common Stock (10,322 underlying)
Footnotes (3)
- [F1]The transaction involved the exercise of fully vested options scheduled to expire in the next 6 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.
- [F2]The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $82.00 to $82.76, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Fully vested.
Signature
Debra A. Cafaro By: /s/ Kenneth Hagan, Attorney-In-Fact|2026-02-10